1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Smith, J.W.
Le Calvez, H.
Parra-Gessert, L.
Preece, N.E.
Jia, X.
Assa-Munt, N.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
277
10298
10305
10.1074/jbc.M108071200
11748219
Selection and structure of ion-selective ligands for platelet integrin alpha IIb(beta) 3.
2002
10.2210/pdb1i6y/pdb
pdb_00001i6y
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
1324.555
ION-SELECTIVE LIGAND A1
1
syn
polymer
no
yes
(ACE)CRVVRGDYLDC(NH2)
XCRVVRGDYLDCX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_site
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2002-07-10
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_conn.pdbx_leaving_atom_flag
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
NMR ENSEMBLE OF ION-SELECTIVE LIGAND A22 FOR PLATELET INTEGRIN ALPHAIIB-BETA3
NMR ENSEMBLE OF ION-SELECTIVE LIGAND D16 FOR PLATELET INTEGRIN ALPHAIIB-BETA3
NMR ENSEMBLE OF ION-SELECTIVE LIGAND D18 FOR PLATELET INTEGRIN ALPHAIIB-BETA3
RCSB
Y
RCSB
2001-03-06
REL
REL
The peptide was chemically synthesized: Commercial solid phase with cyclization via selective disulphide oxidation.
sample
These structures were determined using
standard 2D homonuclear techniques (circa 2000).
structures with the lowest energy
200
15
NOESY & DQF-COSY
3mg/ml
6.5
1
atm
278
K
Ensemble A1 is based on a total of
117 NOE-derived distance constraints,
10 dihedral angle restraints,
1 covalent -SS- bonds and
1 VRGD, i,i+3 hydrogen bonds
respectively.
Refinements incorporated alpha proton
and alpha, beta carbon shifts of 7-11
residues.
restrained molecular dynamics
and chemical shift refinement.
3mg/ml A1
20mM phosphate buffer;
90% H2O, 10% D2O
Varian Inc.
collection
VNMR
6.1B
Hare, D.; Biosym; MSI
processing
Felix
2000
Brunger, A. & Nilges, M.
structure solution
X-PLOR
3.8.5.1
Kuszweski, J. & Clore, G.M.
refinement
X-PLOR
3.8.5.1 (Chem.Shift.Module)
500
Varian
UNITYPLUS
ACE
1
n
1
ACE
1
A
CYS
2
n
2
CYS
2
A
ARG
3
n
3
ARG
3
A
VAL
4
n
4
VAL
4
A
VAL
5
n
5
VAL
5
A
ARG
6
n
6
ARG
6
A
GLY
7
n
7
GLY
7
A
ASP
8
n
8
ASP
8
A
TYR
9
n
9
TYR
9
A
LEU
10
n
10
LEU
10
A
ASP
11
n
11
ASP
11
A
CYS
12
n
12
CYS
12
A
CYS
12
n
13
NH2
13
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
3
0.254
SIDE CHAIN
1
A
ARG
6
0.315
SIDE CHAIN
2
A
ARG
3
0.313
SIDE CHAIN
2
A
ARG
6
0.317
SIDE CHAIN
3
A
ARG
3
0.303
SIDE CHAIN
3
A
ARG
6
0.310
SIDE CHAIN
4
A
ARG
3
0.276
SIDE CHAIN
4
A
ARG
6
0.299
SIDE CHAIN
5
A
ARG
3
0.214
SIDE CHAIN
5
A
ARG
6
0.317
SIDE CHAIN
6
A
ARG
3
0.316
SIDE CHAIN
6
A
ARG
6
0.310
SIDE CHAIN
7
A
ARG
3
0.228
SIDE CHAIN
7
A
ARG
6
0.290
SIDE CHAIN
8
A
ARG
3
0.215
SIDE CHAIN
8
A
ARG
6
0.316
SIDE CHAIN
9
A
ARG
3
0.304
SIDE CHAIN
9
A
ARG
6
0.305
SIDE CHAIN
10
A
ARG
3
0.296
SIDE CHAIN
10
A
ARG
6
0.295
SIDE CHAIN
11
A
ARG
3
0.265
SIDE CHAIN
11
A
ARG
6
0.316
SIDE CHAIN
12
A
ARG
3
0.204
SIDE CHAIN
12
A
ARG
6
0.246
SIDE CHAIN
13
A
ARG
3
0.307
SIDE CHAIN
13
A
ARG
6
0.189
SIDE CHAIN
14
A
ARG
3
0.312
SIDE CHAIN
14
A
ARG
6
0.317
SIDE CHAIN
15
A
ARG
3
0.235
SIDE CHAIN
15
A
ARG
6
0.214
SIDE CHAIN
1
A
ARG
3
-90.49
-104.43
1
A
ASP
8
-142.67
-10.35
1
A
LEU
10
-100.24
-101.19
2
A
VAL
4
-105.29
-94.60
2
A
ASP
8
-160.29
83.99
2
A
LEU
10
-148.80
14.70
3
A
ASP
8
-119.21
66.71
3
A
LEU
10
-98.20
39.57
4
A
ASP
8
-160.35
90.12
4
A
LEU
10
-117.98
64.19
5
A
ARG
3
-104.98
-63.52
5
A
VAL
4
-145.49
-159.63
5
A
VAL
5
-136.89
-72.41
5
A
ASP
8
-155.17
88.89
5
A
LEU
10
-119.83
76.23
6
A
LEU
10
-142.54
45.14
7
A
LEU
10
-107.00
76.99
8
A
ARG
3
-145.52
42.26
8
A
VAL
5
-132.37
-121.18
8
A
ASP
8
-150.05
77.47
8
A
LEU
10
-142.82
50.09
9
A
ASP
8
-115.39
64.36
10
A
ARG
3
-146.20
36.94
10
A
VAL
5
-141.10
-87.40
10
A
LEU
10
-141.83
59.68
11
A
ARG
3
-144.48
-25.72
11
A
VAL
5
-136.01
-75.60
11
A
ASP
8
-154.85
88.78
11
A
LEU
10
-112.42
59.58
12
A
ASP
8
-151.97
64.77
13
A
LEU
10
-97.52
-145.00
14
A
ARG
3
-143.70
23.41
14
A
VAL
5
-142.39
-87.41
14
A
ASP
8
-152.05
88.03
14
A
LEU
10
-100.84
67.55
14
A
ASP
11
-95.26
50.55
15
A
VAL
5
-125.49
-84.39
15
A
LEU
10
-95.19
46.60
NMR ENSEMBLE OF ION-SELECTIVE LIGAND A1 FOR PLATELET INTEGRIN ALPHAIIB-BETA3
1
N
N
disulf
2.022
A
CYS
2
A
SG
CYS
2
1_555
A
CYS
12
A
SG
CYS
12
1_555
covale
1.303
both
A
ACE
1
A
C
ACE
1
1_555
A
CYS
2
A
N
CYS
2
1_555
covale
1.308
both
A
CYS
12
A
C
CYS
12
1_555
A
NH2
13
A
N
NH2
13
1_555
CELL ADHESION
integrin, RGD, CELL ADHESION
1I6Y
PDB
1
1I6Y
1
13
1I6Y
1
13
1I6Y
A
1
1
13
BINDING SITE FOR RESIDUE NH2 A 13
A
NH2
13
Software
3
A
TYR
9
A
TYR
9
3
1_555
A
ASP
11
A
ASP
11
3
1_555
A
CYS
12
A
CYS
12
3
1_555